The pharma giant will also receive a 1% royalty on future U.S. sales of influenza, Covid-19 and other related combination ...

The Department of Health and Human Services has cancelled contracts and pulled funding for 22 mRNA vaccine projects, totaling $500 million, to develop vaccines for respiratory viruses like COVID-19 ...